Do Employers, Probation, or DOT Drug Tests Check for Kratom?

Most employers, probation programs, and DOT drug tests don’t check for kratom. Standard 5-panel, 10-panel, and 12-panel screenings target federally scheduled substances, and since kratom remains unscheduled, its alkaloids, mitragynine and 7-hydroxymitragynine, aren’t included in default testing protocols. The immunoassay antibodies used in routine screens simply don’t cross-react with kratom’s unique molecular structure. However, specialized tests do exist when explicitly ordered. Understanding which situations trigger kratom-specific screening can help you assess your actual risk.

The Short Answer: Most Drug Tests Don’t Screen for Kratom

Why doesn’t kratom appear on standard drug tests? The answer lies in workplace drug policy design. Standard 5-panel, 10-panel, and 12-panel tests target federally regulated substances, marijuana, cocaine, amphetamines, opiates, PCP, benzodiazepines, and barbiturates. Mitragynine and 7-hydroxymitragynine, kratom’s active alkaloids, aren’t included in default cutoff tables.
When you undergo routine kratom and drug testing for employment, you’re typically screened using panels that don’t detect kratom alkaloids. Probation services generally follow similar protocols unless jurisdiction-specific policies dictate otherwise. However, certain situations may warrant additional scrutiny, specialized tests may be ordered for military personnel, individuals on probation, or those involved in legal proceedings requiring substance monitoring.
Specialized immunoassay and LC-MS/MS tests can identify kratom at cutoffs as low as 1-5 ng/mL, but laboratories don’t run these unless explicitly requested. Detection capability exists, it’s simply not deployed in standard screening contexts. For example, Quest Diagnostics offers an “Extended Panel” that specifically includes kratom’s alkaloid mitragynine, but employers must specifically request this additional screening.

Why Standard 5, 10, and 12-Panel Tests Miss Kratom

Standard drug panels target specific federally regulated substances, marijuana, cocaine, amphetamines, opiates, and PCP in 5-panel tests, with expanded versions adding benzodiazepines, barbiturates, and other controlled drugs, but none include kratom’s primary alkaloids, mitragynine and 7-hydroxymitragynine. This exclusion isn’t accidental; these compounds have a unique indole structure that differs chemically from tested opioids and produces no cross-reactivity with standard immunoassay antibodies. If you’re subject to routine workplace or probation screening, kratom won’t appear unless someone explicitly orders a specialized test designed to detect it. When such specialized urine testing is conducted, kratom alkaloids can be detected up to 9 days after last use, depending on individual factors like body weight and liver function.

Panels Target Specific Substances

How does a substance end up on a drug test panel in the first place? SAMHSA drug panels establish federal testing standards based on controlled substance scheduling, documented abuse potential, and workplace safety data. The Department of Transportation (DOT) follows these guidelines precisely, targeting only federally scheduled drugs.
Do employers test for kratom under standard protocols? No, kratom remains unscheduled, automatically excluding it from routine panels.

Detection targets require explicit regulatory designation. Since kratom alkaloids lack federal scheduling, they don’t appear on default cutoff tables regardless of panel complexity. You’ll only encounter kratom screening when organizations consciously request it. This plant-based substance, often used to treat pain and anxiety, can be highly addictive and requires specialized panels with a cutoff of 100 ng/ml for detection. It’s worth noting that high concentrations of kratom may trigger false positives for other opioids on standard screenings, potentially complicating test interpretation.

Kratom Alkaloids Excluded Deliberately

Given kratom’s increasing prevalence, you might expect standard drug panels to detect its alkaloids, yet they don’t. Mitragynine and 7-hydroxymitragynine possess indole-based structures that differ fundamentally from the phenethylamine compounds targeted by routine immunoassays. When you’re wondering does kratom show up on a probation drug test or whether kratom on a 10 panel drug test appears, the answer hinges on deliberate exclusion rather than detection limitations.
Standard panels originated from 1988 SAMHSA mandates, predating widespread kratom awareness by decades. The antibodies in these tests don’t cross-react with kratom’s unique molecular architecture. If you’re asking do jobs test for kratom, most employers rely on cost-effective defaults that exclude non-mandated substances. Kratom-specific immunoassays became commercially available in 2013, well after panel standardization locked in current testing targets. When specialized testing is required, laboratories specifically identify mitragynine, the primary compound associated with kratom to deliver clear, verified results.

Detection Requires Explicit Ordering

Because standard drug panels follow predetermined analyte lists, kratom detection never occurs unless the ordering party explicitly requests it. When you take a kratom 5 panel drug test, the screening targets only marijuana, cocaine, amphetamines, opiates, and PCP, mitragynine and 7-hydroxymitragynine remain invisible.
Laboratories like Labcorp require a separate test code (791750) specifically for kratom alkaloids. Quest Diagnostics excludes kratom from both Base and Plus extended panels. This means your employer or probation officer must consciously add kratom analytes to detect them.
The kratom DOT drug test protocol follows federal guidelines that omit kratom entirely. Detection capability exists, immunoassay screens at 5 ng/mL and LC-MS/MS confirmation at 1 ng/mL are readily available, but technology doesn’t determine results. Program intent and explicit ordering decisions control whether kratom appears on any test report.

How to Know If Your Drug Test Includes Kratom

If you’re uncertain whether your upcoming drug test screens for kratom, you can take direct steps to find out before the test occurs. Contact your testing administrator or human resources department to request the specific panel type and ask whether mitragynine or 7-hydroxymitragynine detection is included. You should also review any testing documentation you’ve received, as this paperwork often specifies the substances covered under the ordered panel. Be aware that some routine testing methods may focus solely on mitragynine and miss the other three diastereomers found in kratom, such as speciociliatine, speciogynine, and mitraciliatine.

Ask Your Testing Administrator

Anyone facing an upcoming drug test can eliminate uncertainty about kratom detection by directly contacting the appropriate testing administrator. You should reach out to your Human Resources department, as HR representatives can provide specific details about which drug panel your employer uses. Request documentation outlining whether a 5-panel, 10-panel, or specialized screening will be administered.
Ask testing administrators directly whether kratom analytes, specifically mitragynine and 7-hydroxymitragynine, are included in the ordered panel. Standard workplace screenings typically exclude kratom, but specialized tests using liquid chromatography-tandem mass spectrometry can detect these alkaloids when specifically requested. Keep in mind that kratom metabolites may cross-react with certain substances during screening, which could potentially lead to false positive results. This cross-reactivity has been specifically linked to false positives for methadone or opioids.
You should also clarify which detection methodology applies to your test. Understanding the distinction between routine screening and specialized testing helps you accurately assess detection likelihood before your scheduled appointment.

Review Testing Documentation

Testing documentation provides concrete answers when direct communication with administrators isn’t possible or doesn’t yield specific details. Request a copy of the testing panel specifications, which typically list all substances screened. Standard 5-panel and 7-panel tests exclude kratom alkaloids entirely, focusing instead on marijuana, cocaine, amphetamines, opiates, and PCP.
Examine the documentation for references to mitragynine or 7-hydroxymitragynine, kratom’s primary alkaloids. If you see mentions of LC/MS-MS confirmatory testing for these specific compounds, kratom screening is included. Some 10-panel tests incorporate kratom alkaloids when specifically requested, so verify the exact analytes covered.
Pay attention to immunoassay thresholds listed. Kratom-specific testing uses initial screening at 5.0 ng/mL with confirmatory thresholds at 1.0 ng/mL. These specifications confirm whether your test targets kratom directly. Results from kratom testing typically take 5 to 10 days to be released to the ordering provider, which is longer than many standard drug panels.

Do Employers Test for Kratom?

Most employers don’t test for kratom because standard drug screening panels exclude it entirely. The 5-panel, 10-panel, and 12-panel tests follow federal templates that target marijuana, cocaine, amphetamines, opioids, and PCP, all controlled substances. Since kratom remains unscheduled federally, it doesn’t appear on these cost-effective industry-standard panels.
However, some employers selectively add kratom testing based on specific circumstances. Safety-sensitive workplaces may include kratom screening, particularly in regions where local use is common or following adverse workplace incidents. Major laboratories like Labcorp and MedTox offer turnkey kratom assays with immunoassay screening at cutoffs as low as 5 ng/mL. These specialized tests are necessary because standard drug tests do not detect mitragynine, the primary active compound in kratom.
Your likelihood of encountering kratom testing depends heavily on your workplace type and jurisdiction. Government agencies, law enforcement, and employers in states with kratom bans may require specialized screening.

Does DOT Test for Kratom? Federal Rules Explained

Although kratom products face FDA enforcement as adulterated substances and California has banned their sale for consumption, the Department of Transportation‘s drug testing program doesn’t screen for kratom or its primary metabolite, 7-hydroxymitragynine. The standard DOT panel tests only for five controlled substance classes: marijuana, cocaine, opiates, amphetamines/methamphetamines, and phencyclidine.
Federal regulations under 49 CFR Part 40 Subpart F govern laboratory testing procedures for safety-sensitive transportation employees. These protocols haven’t been updated to include kratom detection capabilities. You won’t face DOT testing consequences specifically for kratom use, regardless of its FDA status or state-level prohibitions. The abuse potential of kratom is not fully understood because no human abuse potential studies have been conducted, though FDA awarded a grant for such research in September 2024.
This regulatory gap means kratom doesn’t trigger positive results on federally mandated transportation screenings. However, the absence of DOT testing doesn’t reflect safety endorsement, it simply reflects current panel limitations established before kratom’s widespread availability. Kratom and 7-OH products have been linked to six overdose deaths in Los Angeles County, demonstrating these substances carry serious risks despite their absence from standard drug panels.

Probation and Court-Ordered Kratom Testing Risks

If you’re on probation or subject to court-ordered monitoring, you should understand that testing protocols vary considerably by jurisdiction and program type. Standard 5-, 10-, or 12-panel drug tests don’t include kratom alkaloids like mitragynine, but recovery-focused monitoring programs may incorporate specialized panels that target these compounds. When suspicion arises, probation officers can request targeted immunoassay screening or LC-MS/MS confirmation testing capable of detecting kratom at cutoffs as low as 5 ng/mL. Urine tests can detect kratom for up to 5 days after last use, so a 2-week abstinence period is recommended before testing.

Program-Specific Testing Decisions

How probation departments and drug courts handle kratom testing depends largely on jurisdictional policies rather than standardized protocols. If you’re on probation in one of the seven states with kratom bans, Alabama, Arkansas, Indiana, Rhode Island, Vermont, or Wisconsin, you’ll face heightened scrutiny and potential specialized testing.
Courts can prohibit substances that remain legal elsewhere, similar to alcohol restrictions imposed on probationers. Even in states where kratom is legally sold, probation officers, drug courts, and licensed treatment facilities routinely ban its use. When kratom is listed as a prohibited substance in your probation terms, officers can order specialized panels detecting mitragynine and 7-hydroxymitragynine through liquid chromatography-tandem mass spectrometry.
You should understand that these specialized tests require explicit ordering and separate payment by probation departments, making detection jurisdiction-dependent rather than automatic. Since kratom remains federally unscheduled, laboratories do not routinely include it in their standard testing protocols unless specifically requested by supervising authorities.

Recovery Monitoring Panels

Recovery monitoring panels represent a distinct category of drug testing that extends beyond standard workplace screenings, particularly in probation and court-ordered settings. These panels often incorporate specialized testing methods, including liquid chromatography-tandem mass spectrometry, which can identify kratom’s specific alkaloids with high accuracy.
If you’re on probation, your officer can request kratom-specific screening when your conditions explicitly forbid psychoactive substances. Courts in states like Indiana authorize periodic chemical testing under statutes such as Indiana Code 35-38-2-2.3(a)(20), giving probation departments broad discretion over testing protocols.
Your risk increases greatly in recovery treatment programs, where extensive substance monitoring frequently includes kratom detection. Probation officers may also discover kratom during random home inspections. Detection in these contexts often triggers requirements for professional addiction treatment to address underlying substance use patterns.

Specialized Alkaloid Screening

Two primary laboratory methods, liquid chromatography-tandem mass spectrometry (LC-MS/MS) and immunoassay screening, enable courts and probation departments to detect kratom’s signature alkaloids when standard drug panels won’t suffice. LC-MS/MS serves as the gold standard, identifying mitragynine and 7-hydroxymitragynine at thresholds as low as 1.0 ng/mL with structural specificity that distinguishes kratom from opioids.
Immunoassay screening, available commercially since 2013, provides initial detection at 5.0 ng/mL cutoffs. Labcorp’s test 791750 uses this approach before LC-MS/MS confirmation. Quest Diagnostics’ Extended Panel specifically includes mitragynine, while ARUP Laboratories offers mitragynine screens with reflex confirmation.
You’ll face detection windows extending up to nine days with specialized alkaloid assays. Courts typically deploy these methods upon explicit suspicion rather than routine screening, escalating from standard panels when kratom use warrants investigation.

Industries Most Likely to Test for Kratom

Several industries stand out as more likely to include kratom in their drug testing protocols, though testing remains the exception rather than the rule.
Transportation, healthcare, warehousing, manufacturing, and construction represent the sectors where you’ll most likely encounter kratom screening. These industries share a common factor: safety-sensitive job requirements. If you operate heavy machinery, provide patient care, or work in environments where impairment poses significant risk, your employer has stronger incentive to expand beyond standard panels.
Healthcare employers may add kratom due to sedation concerns and potential medication interactions. Transportation companies, while bound by DOT’s standard five-panel requirements, can implement additional non-DOT testing when local kratom prevalence rises or after workplace incidents. Your employer’s decision ultimately depends on perceived risk, budget constraints, and organizational policy rather than technical testing limitations.

Labcorp, Quest, and Other Kratom-Specific Drug Tests

When employers or agencies decide to test for kratom, they turn to specialized laboratory services that detect mitragynine and its metabolites with high accuracy.
Labcorp offers a dedicated Kratom Screen and Confirmation test using immunoassay screening at 5.0 ng/mL, with LC-MS/MS confirmation at 1.0 ng/mL. This test specifically identifies mitragynine and 7-hydroxymitragynine, with results available in 5-10 days.
Quest Diagnostics doesn’t include kratom in standard panels, but you can request specialized testing through immunoassay and LC-MS/MS methods. Detection requires explicit ordering since kratom isn’t part of routine 5-, 10-, or 12-panel screens.
For instant results, products like the Identify Health 12-panel cup include kratom at a 100 ng/mL cutoff alongside other substances. All presumptive positives require mass spectrometry confirmation to eliminate false results from cross-reactivity.

How Long Does Kratom Stay in Your System?

Multiple biological factors determine how long kratom remains detectable in your system, with mitragynine’s half-life serving as the primary variable. Research indicates mitragynine’s half-life ranges from approximately 23-24 hours, though individual variation spans from 3 hours in new users to 39 hours maximum.
Your detection window depends heavily on the testing method used. Urine tests, the most common screening approach, can detect kratom metabolites for 2-5 days in occasional users and up to 2 weeks in chronic users. Blood testing typically reveals kratom for 24-48 hours, extending to 7-9 days in some cases.

Your detection window depends heavily on the testing method used. When evaluating how long kratom stays in body, urine tests, the most common screening method, can detect kratom metabolites for approximately 2, 5 days in occasional users and up to two weeks in chronic users. Blood testing typically identifies kratom for 24, 48 hours, although detection may extend to 7, 9 days in certain cases depending on individual metabolism and usage patterns.

Several factors influence your clearance rate: dosage amount, consumption frequency, liver metabolism efficiency, kidney function, and body composition. Oral administration results in approximately 33-hour elimination compared to 14 hours for intravenous routes.

What a Positive Kratom Test Means for Your Job or Case

Although kratom remains legal in most U.S. states, a positive test result can still carry significant consequences depending on your employment context, legal situation, or role in safety-sensitive transportation.

If you’re on probation, mitragynine’s opioid-like effects can violate terms prohibiting mood-altering substances, even where kratom is legal. Employers using specialized panels from Labcorp or Quest’s Extended Panel will detect mitragynine at cutoffs as low as 1 ng/mL through LC-MS/MS confirmation. In transportation roles, positive results prompt immediate safety concerns due to kratom’s combined stimulant and sedative properties.

Frequently Asked Questions

Can Drinking Extra Water Help Flush Kratom Out of My System Faster?

Drinking extra water won’t noticeably speed up how quickly your body eliminates kratom. While hydration may dilute your urine concentration temporarily, it doesn’t accelerate the metabolic breakdown of mitragynine or 7-hydroxymitragynine. Your liver processes these alkaloids at a relatively fixed rate regardless of fluid intake. Limited research directly addresses hydration’s effect on kratom clearance, but evidence from similar compounds suggests you can’t meaningfully ‘flush’ kratom from your system faster through increased water consumption.

Will Kratom Cause a False Positive for Opioids on Standard Drug Tests?

Pure kratom rarely triggers false positives for traditional opiates on standard immunoassay screens. However, research shows kratom metabolites can cause false positives specifically on the Thermo Scientific CEDIA Methadone Metabolite (EDDP) assay, studies found 50% of kratom-positive specimens showed cross-reactivity. If you test positive, you should request confirmatory mass spectrometry testing, which accurately distinguishes kratom alkaloids from actual opioids. The greater risk comes from contaminated kratom products containing fentanyl or other pharmaceutical opioids.

Does Kratom Show up on Hair Follicle Tests Used by Employers?

Kratom doesn’t typically appear on employer hair follicle tests because standard panels don’t include it. However, specialized labs like USDTL can detect mitragynine in hair for up to 90 days using LC, MS/MS methods with detection limits as low as 0.05 pg/mg. You’ll encounter this testing primarily in forensic or legal contexts rather than routine employment screening, due to the high cost of specialized analysis.

Can I Legally Refuse a Kratom-Specific Drug Test at Work?

You can refuse a kratom-specific drug test, but you’ll likely face consequences. In at-will employment states, employers can terminate you for refusing any company-mandated test, regardless of kratom’s legal status. No federal law protects your refusal since kratom isn’t a controlled substance. Your strongest position exists when you’ve signed no pre-employment consent for kratom testing, or when your state requires reasonable suspicion before authorizing specialized screening beyond standard panels.

Will My Employer Be Notified if I Test Positive for Kratom?

Your employer will only receive notification if they specifically ordered a kratom panel and you test positive. Standard 5-, 10-, or 12-panel tests don’t screen for mitragynine, so there’s nothing to report. If your employer requested specialized testing through labs like Labcorp or Quest’s Extended panel, they’ll receive confirmed positive results within 5-10 days. Labs use LC-MS/MS confirmation before reporting, ensuring accuracy. Notification depends entirely on what your employer chose to test.